Lisa E. Davis
Impact in
- Physiology top 0.5%
- Calcium signaling and nucleotide metabolism
- Adenosine and Purinergic Signaling
- Epidemiology top 1%
- Autophagy in Disease and Therapy
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 4
- Colorectal Cancer Treatments and Studies 3
-
- PI3K/AKT/mTOR signaling in cancer 3
- Ubiquitin and proteasome pathways 2
- Co-authors
- Ravi K. Amaravadi (8 shared papers)Shengfu Piao (4 shared papers)Yunyoung C Chang (3 shared papers)Daniel F. Heitjan (3 shared papers)Laura Pontiggia (3 shared papers)Peter J. O’Dwyer (5 shared papers)Quentin McAfee (2 shared papers)Edward C. Li (1 shared paper)
- Journals
- Blood (4 papers)Autophagy (4 papers)American Journal of Health-System Pharmacy (2 papers)Clinical Cancer Research (2 papers)Cancer Nursing (2 papers)
- Partner nations
- United StatesPuerto RicoIndia
In The Last Decade
Lisa E. Davis
41 papers receiving 2.4k citations
Lisa E. Davis's Hit Papers
Peers
Comparison fields: 5 of 115
- Physiology 340
- Epidemiology 1.3k
- Geriatrics and Gerontology 93
- Cancer Research 292
- Molecular Biology 1.1k
Countries citing papers authored by Lisa E. Davis
This map shows the geographic impact of Lisa E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa E. Davis more than expected).
Fields of papers citing papers by Lisa E. Davis
This network shows the impact of papers produced by Lisa E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa E. Davis. The network helps show where Lisa E. Davis may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisa E. Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme Hit paper breakdown → | 2014 | 420 |
| 2 | 2012 | 327 | |
| 3 | 2014 | 317 | |
| 4 | 2014 | 300 | |
| 5 | 2014 | 245 | |
| 6 | 2019 | 117 | |
| 7 | 2007 | 97 | |
| 8 | 2003 | 93 | |
| 9 | 2005 | 82 | |
| 10 | 2020 | 46 | |
| 11 | 2005 | 42 | |
| 12 | 1994 | 35 | |
| 13 | 2019 | 33 | |
| 14 | 2018 | 27 | |
| 15 | 1993 | 27 | |
| 16 | 1997 | 23 | |
| 17 | 2009 | 22 | |
| 18 | 1994 | 21 | |
| 19 | 1994 | 20 | |
| 20 | 2019 | 20 |
About Lisa E. Davis
Lisa E. Davis is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology and Hematology, having authored 43 papers that have together received 2.4k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (7 papers), Multiple Myeloma Research and Treatments (6 papers), Cancer Treatment and Pharmacology (4 papers), Advanced Breast Cancer Therapies (4 papers), Colorectal Cancer Treatments and Studies (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Physiology (340 citations), Epidemiology (1.3k citations), Geriatrics and Gerontology (93 citations), Cancer Research (292 citations) and Molecular Biology (1.1k citations). Lisa E. Davis has collaborated with scholars based in United States, Puerto Rico and India. Frequent co-authors include Ravi K. Amaravadi, Shengfu Piao, Yunyoung C Chang, Daniel F. Heitjan, Laura Pontiggia, Peter J. O’Dwyer, Quentin McAfee, Edward C. Li, Andrea B. Troxel and Reshma Rangwala. Their work appears in journals such as Blood, Autophagy, American Journal of Health-System Pharmacy, Clinical Cancer Research and Cancer Nursing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.